Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9603 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.9172 |
High Similarity |
NPD6959 |
Discontinued |
0.9119 |
High Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8917 |
High Similarity |
NPD7768 |
Phase 2 |
0.8903 |
High Similarity |
NPD7411 |
Suspended |
0.8882 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8792 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8792 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.879 |
High Similarity |
NPD7819 |
Suspended |
0.8758 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8742 |
High Similarity |
NPD7075 |
Discontinued |
0.8733 |
High Similarity |
NPD1549 |
Phase 2 |
0.872 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8718 |
High Similarity |
NPD4380 |
Phase 2 |
0.8671 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.865 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.865 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.865 |
High Similarity |
NPD6166 |
Phase 2 |
0.8553 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8477 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8411 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8395 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8375 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8333 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8293 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8282 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8274 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8267 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8261 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8255 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8225 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8194 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8187 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8176 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8158 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8155 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.814 |
Intermediate Similarity |
NPD8312 |
Approved |
0.814 |
Intermediate Similarity |
NPD8313 |
Approved |
0.8129 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8121 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.811 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8101 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.807 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8039 |
Intermediate Similarity |
NPD6651 |
Approved |
0.8025 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7988 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7988 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7987 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7987 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7976 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7962 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7953 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7919 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7914 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7898 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7895 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7892 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7888 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7874 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.784 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7831 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7821 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7821 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7791 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7771 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7771 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7771 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7759 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7747 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7744 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7735 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7735 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7722 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7716 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7716 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7716 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7716 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7716 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7709 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7707 |
Intermediate Similarity |
NPD3748 |
Approved |
0.767 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7658 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7651 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7644 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7636 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7636 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7625 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7622 |
Intermediate Similarity |
NPD920 |
Approved |
0.7619 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7595 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7593 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7579 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7578 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7578 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7578 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7545 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7533 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7531 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7516 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.75 |
Intermediate Similarity |
NPD7698 |
Approved |
0.75 |
Intermediate Similarity |
NPD7697 |
Approved |
0.75 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7469 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.746 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.746 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7457 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7456 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7438 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7438 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7438 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7438 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7436 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7436 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7414 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7409 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7409 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7405 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7405 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7403 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7403 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7391 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7375 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7356 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7344 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.734 |
Intermediate Similarity |
NPD6777 |
Approved |
0.734 |
Intermediate Similarity |
NPD6780 |
Approved |
0.734 |
Intermediate Similarity |
NPD6779 |
Approved |
0.734 |
Intermediate Similarity |
NPD6781 |
Approved |
0.734 |
Intermediate Similarity |
NPD6782 |
Approved |
0.734 |
Intermediate Similarity |
NPD6776 |
Approved |
0.734 |
Intermediate Similarity |
NPD6778 |
Approved |
0.734 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7338 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7338 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7322 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7316 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7305 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7299 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7294 |
Intermediate Similarity |
NPD7577 |
Discontinued |
0.7292 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7289 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7289 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7288 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7288 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7288 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7288 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7283 |
Intermediate Similarity |
NPD919 |
Approved |
0.7267 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7261 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7257 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7257 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7253 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7246 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7234 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7234 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7233 |
Intermediate Similarity |
NPD943 |
Approved |
0.7231 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7229 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7229 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7216 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7215 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7213 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7205 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.72 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7188 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7188 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7188 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7179 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7179 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7178 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7175 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7173 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7151 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7151 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7143 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7134 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7125 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7125 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7115 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7115 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7111 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.711 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7107 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7097 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7093 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7093 |
Intermediate Similarity |
NPD37 |
Approved |
0.7091 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7086 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7078 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7078 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7074 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7074 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7069 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7069 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7069
|
Intermediate Similarity |
NPD4967 |
Phase 2 |